MedPath

Prediction of Patient Deterioration Using Machine Learning

Conditions
Chronic Obstructive Pulmonary Disease
Asthma
Gout Flare
Chronic Kidney Diseases
Anticoagulants; Increased
Infection
Atrial Fibrillation Rapid
Heart Failure
Hypertensive Urgency
Interventions
Other: Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
Registration Number
NCT05045742
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict patient deterioration throughout a patient's admission. This algorithm was then validated in a validation cohort.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria

Cared for in the Brigham and Women's Home Hospital study

Exclusion Criteria

Incomplete continuous monitoring data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ValidationTraditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2A subset of patients that are "held back" and used to validate the algorithm's accuracy.
TrainingTraditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2A subset of patients that are used to train the machine learning algorithm.
Primary Outcome Measures
NameTimeMethod
Alarm burdenFrom admission to discharge, measured in hours, on average 5 days

The number of alarms fired per patient per hour

Secondary Outcome Measures
NameTimeMethod
Rate of alarms with clinical utilityFrom admission to discharge, on average 5 days

We will use general estimating equations (GEE) with three outcomes per patient (the number of clinically important alarms for BioVitals, NEWS2, and traditional vital signs); the GEE will account for the clustering between the three outcomes on a patient. The GEE will use a negative binomial marginal model with a log-link for the number of alarms with clinical utility and an offset for log length-of stay (in hours); with this model, we model the rate per hour of number of alarms with clinical utility with BI, NEWS2, and traditional vital signs. The main covariate in the negative binomial model will be a three-level covariate for method: BI vs NEWS2 vs traditional vital signs, and the exponential of the effect of this covariate will be a pair-wise rate ratio for BI vs NEWS2 vs traditional vital signs.

Specificity for recognition of a safety compositeFrom admission to discharge, on average 5 days

The specificity (true negatives divided by condition negatives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).

Positive predictive value for recognition of a safety compositeFrom admission to discharge, on average 5 days

The positive predictive value (true positives divided by the sum of true positives plus false positives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).

Sensitivity for recognition of a safety compositeFrom admission to discharge, on average 5 days

The sensitivity (true positives divided by condition positives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).

Negative predictive value for recognition of a safety compositeFrom admission to discharge, on average 5 days

The negative predictive value (true negatives divided by the sum of true negatives plus false negatives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).

Trial Locations

Locations (2)

Brigham and Women's Faulkner Hospital

🇺🇸

Boston, Massachusetts, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath